HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text (PDF) References Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Add to Personal Folders Download to citation manager Author home page(s): George L. Hicks, Jr. James A. DeWeese Permission Requests Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Hicks, G. L. Articles by DeWeese, J. A. Search for Related Content PubMed PubMed Citation Articles by Hicks, G. L., Jr. Articles by DeWeese, J. A.

Ann Thorac Surg 1985;39:324-328
© 1985 The Society of Thoracic Surgeons

---

Articles

Verapamil Potassium Cardioplegia and Cardiac Conduction

Division of Cardiothoracic Surgery, University of Rochester Medical Center, Rochester, NY

Accepted for publication July 16, 1984.

^* Address reprint requests to Dr. Hicks, University of Rochester Medical Center, 601 Elmwood Ave, Rochester, NY 14642

This clinical study analyzes the effect of potassium cardioplegic solution containing verapamil hydrochloride (1 mg/L) on cardiac conduction after release of the aortic cross-clamp and throughout recovery. Fifty consecutive patients undergoing open-heart operation were studied as a unit for postoperative conduction abnormalities. They were also analyzed in groups based on spontaneous ventricular conversion to regular rhythm (54%) and the need for single DC cardioversion (32%), or multiple DC cardioversions (14%).

Results showed that spontaneous ventricular conversion had no relationship to aortic cross-clamp time and that DC cardioversion using 10 Ws had no detrimental effects on the myocardium or incidence of conduction abnormalities. The need for transient intraoperative pacing was lowest with spontaneous ventricular conversion, but not statistically different from single or multiple DC cardioversions. Only 3 patients (6%) required pacing in the intensive care unit. The incidence of postoperative atrial and ventricular arrhythmias was similar in all groups, and no deaths or episodes of malignant ventricular arrhythmias occurred.

This study concludes that verapamil potassium cardioplegia is associated with excellent myocardial protection and a high incidence of transient intraoperative dysfunction of the atrioventricular node (70%) but a low incidence of postoperative pacing. Benign postoperative arrhythmias occur, but at hospital discharge, few conduction abnormalities (10%) persist.

This article has been cited by other articles:

				G. S. Weinstein, P. S. Rao, and D. H. Tyras Reduction of myocardial injury with verapamil before aortic cross-clamping Ann. Thorac. Surg., March 1, 1990; 49(3): 419 - 423. [Abstract] [PDF]

				R. W. Landymore, A. E. Marble, A. Trillo, G. Faulkner, M. A. MacAulay, and C. Cameron Prevention of Myocardial Electrical Activity during Ischemic Arrest with Verapamil Cardioplegia Ann. Thorac. Surg., May 1, 1987; 43(5): 534 - 538. [Abstract] [PDF]

				J. W. de Jong Cardioplegia and Calcium Antagonists: A Review Ann. Thorac. Surg., November 1, 1986; 42(5): 593 - 598. [Abstract] [PDF]

				A. V. Guffin, R. A. Kates, G. W. Holbrook, E. L. Jones, and J. A. Kaplan Verapamil and Myocardial Preservation in Patients Undergoing Coronary Artery Bypass Surgery Ann. Thorac. Surg., June 1, 1986; 41(6): 587 - 591. [Abstract] [PDF]